US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Aduro Biotech Inc (ADRO)
Aduro Biotech Inc (ADRO) ニュース

ADRO

Aduro Biotech (ADRO)

Aduro Biotech Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ADRO

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/06/20	22 : 06	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ADRO	Aduro Biotech Inc
2023/06/20	22 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ADRO	Aduro Biotech Inc
2023/06/16	05 : 18	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ADRO	Aduro Biotech Inc
2023/06/14	22 : 02	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ADRO	Aduro Biotech Inc
2023/06/13	05 : 30	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ADRO	Aduro Biotech Inc
2023/06/13	05 : 28	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ADRO	Aduro Biotech Inc
2023/06/13	05 : 07	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ADRO	Aduro Biotech Inc
2023/06/12	22 : 42	Edgar (US Regulatory)	Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)	NASDAQ:ADRO	Aduro Biotech Inc
2023/06/12	20 : 05	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ADRO	Aduro Biotech Inc
2023/06/12	20 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ADRO	Aduro Biotech Inc
2023/06/01	08 : 26	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADRO	Aduro Biotech Inc
2023/06/01	08 : 23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADRO	Aduro Biotech Inc
2023/06/01	08 : 22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADRO	Aduro Biotech Inc
2023/05/10	05 : 10	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ADRO	Aduro Biotech Inc
2023/05/10	05 : 04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ADRO	Aduro Biotech Inc
2023/05/06	05 : 02	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ADRO	Aduro Biotech Inc
2023/04/29	06 : 43	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:ADRO	Aduro Biotech Inc
2023/04/27	06 : 20	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADRO	Aduro Biotech Inc
2023/04/20	06 : 59	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADRO	Aduro Biotech Inc
2023/04/18	05 : 52	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:ADRO	Aduro Biotech Inc
2023/04/14	05 : 32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ADRO	Aduro Biotech Inc
2023/04/13	05 : 57	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ADRO	Aduro Biotech Inc
2023/03/13	19 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ADRO	Aduro Biotech Inc
2023/03/11	06 : 14	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:ADRO	Aduro Biotech Inc
2023/03/04	06 : 13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADRO	Aduro Biotech Inc
2023/02/28	06 : 05	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ADRO	Aduro Biotech Inc
2023/02/17	07 : 53	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ADRO	Aduro Biotech Inc
2023/02/16	06 : 41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADRO	Aduro Biotech Inc
2023/02/16	06 : 40	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADRO	Aduro Biotech Inc
2023/02/15	06 : 34	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ADRO	Aduro Biotech Inc

Showing the most relevant articles for your search:NASDAQ:ADRO

1 2 3 4 5 6 7 8 9 10 次へ >>

BNP Paribas (QX)

Health Care Select Sector

US Dollar vs Sterling

Gold vs US Dollar

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約